CXCL16 and central nervous system cancer: CXCL16/CXCR6 axis acts a pivotal part in the pro-tumor microenvironment, and the silencing of CXCR6 reduced the proliferation rate on glioma cells (Lepore et al., 2018), indicating that CXCR6 plays an oncogenic role in glioma.